becaplermin (REGRANEX) (GEL) 100 ug/g

Becaplermin gel 100 mcg/g is a prescription topical treatment for diabetic foot ulcers. This recombinant human platelet-derived growth factor promotes wound healing in chronic ulcers. Designed for external use only, it supports tissue repair when used as directed.

Strength

100 ug/g

Manufacturer / TM Owner

Smith & Nephew, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Becaplermin gel 100 mcg/g is used to treat diabetic foot ulcers, helping to close wounds that have not responded to standard care. It works by stimulating new cell growth and tissue repair at the ulcer site. People often ask what becaplermin gel is used for when managing slow-healing wounds.

Side Effects

Applied directly to the wound bed, becaplermin gel 100 mcg/g supports the natural healing process by encouraging new tissue formation. Users may notice gradual reduction in wound size and improved skin appearance over time with consistent application.

Precautions & Warnings

Keep becaplermin gel 100 mcg/g away from healthy skin and avoid contact with eyes or mucous membranes. Use only as prescribed and follow wound care instructions provided by a healthcare professional. Wash hands before and after application to prevent contamination.

Avoid Interactions

No specific drug interactions are widely reported with becaplermin gel 100 mcg/g, but inform your provider about all medications and supplements. Avoid using other topical treatments on the same wound unless directed. Keep the product away from strong antiseptics or cleansing agents.

Frequently Asked Questions

It is used to treat diabetic foot ulcers that have not improved with standard wound care.

Apply a thin layer directly to the cleaned ulcer bed once daily and cover with a dressing as directed.

Some users may experience mild skin reactions at the application site, such as redness or irritation.

It is intended for diabetic foot ulcers only and should not be used on infected or non-diabetic wounds.

Healing time varies; consistent use over several weeks is typically required to see improvement.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.